Higher levels of peroxides, malondialdehyde, superoxide dismutase, nitric oxide, lower HDL-cholesterol, and paraoxonase 1 (an antioxidant enzyme) are neuro-oxidative toxicity markers which predict lower WHO-QoL scores in patients with BD/MDD (29–31). The gene discussed is PON1; the disease is Behcet disease.